DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer

References

• Barlow DP, Bartolomei MS. Genomic imprinting in mammals. Cold Spring Harb Perspect Biol. 2014;6(2):a018382.
   PubMed Web of Science ®Google Scholar
• McGrath J, Solter D. Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell. 1984;37(1):179–183.
   PubMed Web of Science ®Google Scholar
• Surani MA, Barton SC, Norris ML. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature. 1984;308(5959):548–550.
   PubMed Web of Science ®Google Scholar
• Engel E. A fascination with chromosome rescue in uniparental disomy: Mendelian recessive outlaws and imprinting copyrights infringements. Eur J Hum Genet. 2006;14(11):1158–1169.
   PubMed Web of Science ®Google Scholar
• Kotzot D. Prenatal testing for uniparental disomy: indications and clinical relevance. Ultrasound Obstet Gynecol. 2008;31(1):100–105.
   PubMed Web of Science ®Google Scholar
• Ogata T, Kagami M, Ferguson-Smith AC. Molecular mechanisms regulating phenotypic outcome in paternal and maternal uniparental disomy for chromosome 14. Epigenetics. 2008;3(4):181–187.
   PubMed Web of Science ®Google Scholar
• Cattanach B, Rasberry C. Evidence of imprinting involving the distal region of Chr 12. Mouse Genome. 1993;91(5):858.
   Google Scholar
• Kamnasaran D, Cox DW. Current status of human chromosome 14. J Med Genet. 2002;39(2):81–90.
   PubMed Web of Science ®Google Scholar
• Hagan JP, O’Neill BL, Stewart CL, et al. At least ten genes define the imprinted Dlk1-Dio3 cluster on mouse chromosome 12qF1. PLoS One. 2009;4(2):e4352.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Wagatsuma H, Ono R, et al. Mouse Peg9/Dlk1 and human PEG9/DLK1 are paternally expressed imprinted genes closely located to the maternally expressed imprinted genes: mouse Meg3/Gtl2 and human MEG3. Genes Cells. 2000;5(12):1029–1037.
   PubMed Web of Science ®Google Scholar
• Takada S, Tevendale M, Baker J, et al. Delta-like and gtl2 are reciprocally expressed, differentially methylated linked imprinted genes on mouse chromosome 12. Curr Biol. 2000;10(18):1135–1138.
   PubMed Web of Science ®Google Scholar
• Charlier C, Segers K, Wagenaar D, et al. Human–ovine comparative sequencing of a 250-kb imprinted domain encompassing the callipyge (clpg) locus and identification of six imprinted transcripts: DLK1, DAT, GTL2, PEG11, antiPEG11, and MEG8. Genome Res. 2001;11(5):850–862.
   PubMed Web of Science ®Google Scholar
• Hernandez A, Fiering S, Martinez E, et al. The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts. Endocrinology. 2002;143(11):4483–4486.
   PubMed Web of Science ®Google Scholar
• Hernandez A, Martinez ME, Croteau W, et al. Complex organization and structure of sense and antisense transcripts expressed from the DIO3 gene imprinted locus. Genomics. 2004;83(3):413–424.
   PubMed Web of Science ®Google Scholar
• Tierling S, Dalbert S, Schoppenhorst S, et al. High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12. Genomics. 2006;87(2):225–235.
   PubMed Web of Science ®Google Scholar
• Schuster-Gossler K, Bilinski P, Sado T, et al. The mouse Gtl2 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA. Dev Dyn. 1998;212(2):214–228.
   PubMed Web of Science ®Google Scholar
• Miyoshi N, Wagatsuma H, Wakana S, et al. Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells. 2000;5(3):211–220.
   PubMed Web of Science ®Google Scholar
• Seitz H, Royo H, Bortolin ML, et al. A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res. 2004;14(9):1741–1748.
   PubMed Web of Science ®Google Scholar
• Seitz H, Youngson N, Lin SP, et al. Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. Nat Genet. 2003;34(3):261–262.
   PubMed Web of Science ®Google Scholar
• Davis E, Caiment F, Tordoir X, et al. RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus. Curr Biol. 2005;15(8):743–749.
   PubMed Web of Science ®Google Scholar
• Cavaille J, Seitz H, Paulsen M, et al. Identification of tandemly-repeated C/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi/Angelman syndrome region. Hum Mol Genet. 2002;11(13):1527–1538.
   PubMed Web of Science ®Google Scholar
• Luo Z, Lin C, Woodfin AR, et al. Regulation of the imprinted Dlk1-Dio3 locus by allele-specific enhancer activity. Genes Dev. 2016;30(1):92–101.
   PubMed Web of Science ®Google Scholar
• Enfield KS, Martinez VD, Marshall EA, et al. Deregulation of small non-coding RNAs at the DLK1-DIO3 imprinted locus predicts lung cancer patient outcome. Oncotarget. 2016;7(49):80957–80966.
   PubMed Web of Science ®Google Scholar
• Hiura H, Komiyama J, Shirai M, et al. DNA methylation imprints on the IG-DMR of the Dlk1-Gtl2 domain in mouse male germline. FEBS Lett. 2007;581(7):1255–1260.
   PubMed Web of Science ®Google Scholar
• Lin SP, Coan P, Da Rocha ST, et al. Differential regulation of imprinting in the murine embryo and placenta by the Dlk1-Dio3 imprinting control region. Development. 2007;134(2):417–426.
   PubMed Web of Science ®Google Scholar
• Sato S, Yoshida W, Soejima H, et al. Methylation dynamics of IG-DMR and Gtl2-DMR during murine embryonic and placental development. Genomics. 2011;98(2):120–127.
   PubMed Web of Science ®Google Scholar
• Carr MS, Yevtodiyenko A, Schmidt CL, et al. Allele-specific histone modifications regulate expression of the Dlk1-Gtl2 imprinted domain. Genomics. 2007;89(2):280–290.
   PubMed Web of Science ®Google Scholar
• Lin SP, Youngson N, Takada S, et al. Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12. Nat Genet. 2003;35(1):97–102.
   PubMed Web of Science ®Google Scholar
• Kota SK, Lleres D, Bouschet T, et al. ICR noncoding RNA expression controls imprinting and DNA replication at the Dlk1-Dio3 domain. Dev Cell. 2014;31(1):19–33.
   PubMed Web of Science ®Google Scholar
• Das PP, Hendrix DA, Apostolou E, et al. PRC2 is required to maintain expression of the maternal Gtl2-rian-mirg locus by preventing de novo DNA methylation in mouse embryonic stem cells. Cell Rep. 2015;12(9):1456–1470.
   PubMed Web of Science ®Google Scholar
• Steshina EY, Carr MS, Glick EA, et al. Loss of imprinting at the Dlk1-Gtl2 locus caused by insertional mutagenesis in the Gtl2 5ʹ region. BMC Genet. 2006;7:44.
   PubMed Web of Science ®Google Scholar
• Sekita Y, Wagatsuma H, Irie M, et al. Aberrant regulation of imprinted gene expression in Gtl2lacZ mice. Cytogenet Genome Res. 2006;113(1–4):223–229.
   PubMed Web of Science ®Google Scholar
• Sekita Y, Wagatsuma H, Nakamura K, et al. Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta. Nat Genet. 2008;40(2):243–248.
   PubMed Web of Science ®Google Scholar
• Georgiades P, Watkins M, Surani MA, et al. Parental origin-specific developmental defects in mice with uniparental disomy for chromosome 12. Development. 2000;127(21):4719–4728.
   PubMed Web of Science ®Google Scholar
• Li J, Wang Y, Luo J, et al. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. FEBS Lett. 2012;586(20):3761–3765.
   PubMed Web of Science ®Google Scholar
• Prats-Puig A, Carreras-Badosa G, Bassols J, et al. The placental imprinted DLK1-DIO3 domain: a new link to prenatal and postnatal growth in human beings. Am J Obstet Gynecol. 2017.
   PubMedGoogle Scholar
• Da Rocha ST, Tevendale M, Knowles E, et al. Restricted co-expression of Dlk1 and the reciprocally imprinted non-coding RNA, Gtl2: implications for cis-acting control. Dev Biol. 2007;306(2):810–823.
   PubMed Web of Science ®Google Scholar
• Costaglioli P, Come C, Knoll-Gellida A, et al. The homeotic protein dlk is expressed during peripheral nerve development. FEBS Lett. 2001;509(3):413–416.
   PubMed Web of Science ®Google Scholar
• Kagami M, Kurosawa K, Miyazaki O, et al. Comprehensive clinical studies in 34 patients with molecularly defined UPD(14)pat and related conditions (Kagami-Ogata syndrome). Eur J Hum Genet. 2015;23(11):1488–1498.
   PubMed Web of Science ®Google Scholar
• Moon YS, Smas CM, Lee K, et al. Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol. 2002;22(15):5585–5592.
   PubMed Web of Science ®Google Scholar
• Ferron SR, Charalambous M, Radford E, et al. Postnatal loss of Dlk1 imprinting in stem cells and niche astrocytes regulates neurogenesis. Nature. 2011;475(7356):381–385.
   PubMed Web of Science ®Google Scholar
• Kitazawa M, Tamura M, Kaneko-Ishino T, et al. Severe damage to the placental fetal capillary network causes mid- to late fetal lethality and reduction in placental size in Peg11/Rtl1 KO mice. Genes Cells. 2017;22(2):174–188.
   PubMed Web of Science ®Google Scholar
• Peeters RP, Hernandez A, Ng L, et al. Cerebellar abnormalities in mice lacking type 3 deiodinase and partial reversal of phenotype by deletion of thyroid hormone receptor alpha1. Endocrinology. 2013;154(1):550–561.
   PubMed Web of Science ®Google Scholar
• D’haene E, Jacobs EZ, Volders P-J, et al. Identification of long non-coding RNAs involved in neuronal development and intellectual disability. Sci Rep. 2016;6.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Okamoto A, Kobayashi R, et al. Deletion of Gtl2, imprinted non-coding RNA, with its differentially methylated region induces lethal parent-origin-dependent defects in mice. Hum Mol Genet. 2009;18(10):1879–1888.
   PubMed Web of Science ®Google Scholar
• O’Brien K, Lowry MC, Corcoran C, et al. miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity. Oncotarget. 2015;6(32):32774–32789.
   PubMed Web of Science ®Google Scholar
• Da Rocha ST, Charalambous M, Lin SP, et al. Gene dosage effects of the imprinted delta-like homologue 1 (dlk1/pref1) in development: implications for the evolution of imprinting. PLoS Genet. 2009;5(2):e1000392.
   PubMed Web of Science ®Google Scholar
• Al-Harbi S, Choudhary GS, Ebron JS, et al. miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies. Mol Cancer. 2015;14:185.
   PubMed Web of Science ®Google Scholar
• Hernandez A, Martinez ME, Fiering S, et al. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest. 2006;116(2):476–484.
   PubMed Web of Science ®Google Scholar
• Boney CM, Fiedorek FT Jr., Paul SR, et al. Regulation of preadipocyte factor-1 gene expression during 3T3-L1 cell differentiation. Endocrinology. 1996;137(7):2923–2928.
   PubMed Web of Science ®Google Scholar
• Cleaton MA, Dent CL, Howard M, et al. Fetus-derived DLK1 is required for maternal metabolic adaptations to pregnancy and is associated with fetal growth restriction. Nat Genet. 2016;48(12):1473–1480.
   PubMed Web of Science ®Google Scholar
• Waddell JN, Zhang P, Wen Y, et al. Dlk1 is necessary for proper skeletal muscle development and regeneration. PLoS One. 2010;5(11):e15055.
   PubMed Web of Science ®Google Scholar
• Labialle S, Marty V, Bortolin-Cavaille ML, et al. The miR-379/miR-410 cluster at the imprinted Dlk1-Dio3 domain controls neonatal metabolic adaptation. Embo J. 2014;33(19):2216–2230.
   PubMed Web of Science ®Google Scholar
• Rago L, Beattie R, Taylor V, et al. miR379-410 cluster miRNAs regulate neurogenesis and neuronal migration by fine-tuning N-cadherin. Embo J. 2014;33(8):906–920.
   PubMed Web of Science ®Google Scholar
• Ioannides Y, Lokulo-Sodipe K, Mackay DJ, et al. Temple syndrome: improving the recognition of an underdiagnosed chromosome 14 imprinting disorder: an analysis of 51 published cases. J Med Genet. 2014;51(8):495–501.
   PubMed Web of Science ®Google Scholar
• Kagami M, Mizuno S, Matsubara K, et al. Epimutations of the IG-DMR and the MEG3-DMR at the 14q32.2 imprinted region in two patients with Silver-Russell Syndrome-compatible phenotype. Eur J Hum Genet. 2015;23(8):1062–1067.
   PubMed Web of Science ®Google Scholar
• Bens S, Kolarova J, Gillessen-Kaesbach G, et al. The differentially methylated region of MEG8 is hypermethylated in patients with Temple syndrome. Epigenomics. 2015;7(7):1089–1097.
   PubMed Web of Science ®Google Scholar
• Briggs TA, Lokulo-Sodipe K, Chandler KE, et al. Temple syndrome as a result of isolated hypomethylation of the 14q32 imprinted DLK1/MEG3 region. Am J Med Genet A. 2016;170A(1):170–175.
   Web of Science ®Google Scholar
• Kagami M, Sekita Y, Nishimura G, et al. Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat Genet. 2008;40(2):237–242.
   PubMed Web of Science ®Google Scholar
• Rosenfeld JA, Fox JE, Descartes M, et al. Clinical features associated with copy number variations of the 14q32 imprinted gene cluster. Am J Med Genet A. 2015;167A(2):345–353.
   PubMed Web of Science ®Google Scholar
• Severi G, Bernardini L, Briuglia S, et al. New patients with Temple syndrome caused by 14q32 deletion: genotype-phenotype correlations and risk of thyroid cancer. Am J Med Genet A. 2016;170A(1):162–169.
   Web of Science ®Google Scholar
• Beygo J, Elbracht M, De Groot K, et al. Novel deletions affecting the MEG3-DMR provide further evidence for a hierarchical regulation of imprinting in 14q32. Eur J Hum Genet. 2015;23(2):180–188.
   PubMed Web of Science ®Google Scholar
• van der Werf IM, Buiting K, Czeschik C, et al. Novel microdeletions on chromosome 14q32.2 suggest a potential role for non-coding RNAs in Kagami-Ogata syndrome. Eur J Hum Genet. 2016;24(12):1724–1729.
   PubMed Web of Science ®Google Scholar
• Curtis L, Antonelli E, Vial Y, et al. Prenatal diagnostic indicators of paternal uniparental disomy 14. Prenat Diagn. 2006;26(8):662–666.
   PubMed Web of Science ®Google Scholar
• Yamanaka M, Ishikawa H, Saito K, et al. Prenatal findings of paternal uniparental disomy 14: report of four patients. Am J Med Genet A. 2010;152A(3):789–791.
   PubMed Web of Science ®Google Scholar
• Kagami M, O’Sullivan MJ, Green AJ, et al. The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers. PLoS Genet. 2010;6(6):e1000992.
   PubMed Web of Science ®Google Scholar
• Tsukishiro S, Li QY, Tanemura M, et al. Paternal uniparental disomy of chromosome 14 and unique exchange of chromosome 7 in cases of spontaneous abortion. J Hum Genet. 2005;50(3):112–117.
   PubMed Web of Science ®Google Scholar
• Kagami M, Nishimura G, Okuyama T, et al. Segmental and full paternal isodisomy for chromosome 14 in three patients: narrowing the critical region and implication for the clinical features. Am J Med Genet A. 2005;138A(2):127–132.
   PubMed Web of Science ®Google Scholar
• Mattes J, Whitehead B, Liehr T, et al. Paternal uniparental isodisomy for chromosome 14 with mosaicism for a supernumerary marker chromosome 14. Am J Med Genet A. 2007;143A(18):2165–2171.
   PubMed Web of Science ®Google Scholar
• Ogata T, Kagami M. Kagami-Ogata syndrome: a clinically recognizable upd(14)pat and related disorder affecting the chromosome 14q32.2 imprinted region. J Hum Genet. 2016;61(2):87–94.
   PubMed Web of Science ®Google Scholar
• Ito M, Sferruzzi-Perri AN, Edwards CA, et al. A trans-homologue interaction between reciprocally imprinted miR-127 and Rtl1 regulates placenta development. Development. 2015;142(14):2425–2430.
   PubMed Web of Science ®Google Scholar
• Mo CF, Wu FC, Tai KY, et al. Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines. Stem Cell Res Ther. 2015;6:1.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zou Y, Wang W, et al. Down-regulated long non-coding RNA MEG3 and its effect on promoting apoptosis and suppressing migration of trophoblast cells. J Cell Biochem. 2015;116(4):542–550.
   PubMed Web of Science ®Google Scholar
• Becker-Santos DD, Thu KL, English JC, et al. Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma. J Pathol. 2016;240(2):161–172.
   PubMed Web of Science ®Google Scholar
• DiFiore JW, Wilson JM. Lung development. Semin Pediatr Surg. 1994;3(4):221–232.
   PubMedGoogle Scholar
• Yevtodiyenko A, Schmidt JV. Dlk1 expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta. Dev Dyn. 2006;235(4):1115–1123.
   PubMed Web of Science ®Google Scholar
• Tsao PN, Matsuoka C, Wei SC, et al. Epithelial Notch signaling regulates lung alveolar morphogenesis and airway epithelial integrity. Proc Natl Acad Sci U S A. 2016;113(29):8242–8247.
   PubMed Web of Science ®Google Scholar
• Falix FA, Mrs T-A-L, Gaemers IC, et al. DLK1 protein expression during mouse development provides new insights into its function. ISRN Dev Biol. 2013;10:2013.
   Google Scholar
• Weng T, Gao L, Bhaskaran M, et al. Pleiotrophin regulates lung epithelial cell proliferation and differentiation during fetal lung development via beta-catenin and Dlk1. J Biol Chem. 2009;284(41):28021–28032.
   PubMed Web of Science ®Google Scholar
• Han Z, He H, Zhang F, et al. Spatiotemporal expression pattern of Mirg, an imprinted non-coding gene, during mouse embryogenesis. J Mol Histol. 2012;43(1):1–8.
   PubMed Web of Science ®Google Scholar
• Bhaskaran M, Wang Y, Zhang H, et al. MicroRNA-127 modulates fetal lung development. Physiol Genomics. 2009;37(3):268–278.
   PubMed Web of Science ®Google Scholar
• Williams AE, Moschos SA, Perry MM, et al. Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev Dyn. 2007;236(2):572–580.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang H, Zhang S, et al. MiR-134 functions as a regulator of cell proliferation, apoptosis, and migration involving lung septation. In Vitro Cell Dev Biol Anim. 2012;48(2):131–136.
   PubMed Web of Science ®Google Scholar
• Valdmanis PN, Roy-Chaudhuri B, Kim HK, et al. Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma. Oncogene. 2015;34(1):94–103.
   PubMed Web of Science ®Google Scholar
• Nadal E, Zhong J, Lin J, et al. A microRNA cluster at 14q32 drives aggressive lung adenocarcinoma. Clin Cancer Res. 2014;20(12):3107–3117.
   PubMed Web of Science ®Google Scholar
• Qin Q, Wei F, Zhang J, et al. miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor. J Cell Mol Med. 2016;20(10):1974–1983.
   PubMed Web of Science ®Google Scholar
• Kitamura K, Seike M, Okano T, et al. MiR-134/487b/655 cluster regulates TGF-beta-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther. 2014;13(2):444–453.
   PubMed Web of Science ®Google Scholar
• Chen X, Xu Y, Liao X, et al. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Tumour Biol. 2016;37(9):11927–11936.
   PubMed Web of Science ®Google Scholar
• Sun CC, Li SJ, Zhang F, et al. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer. Oncotarget. 2016;7(16):21510–21526.
   PubMed Web of Science ®Google Scholar
• Lu YJ, Liu RY, Hu K, et al. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer. Tumour Biol. 2016;37(9):12685–12695.
   PubMed Web of Science ®Google Scholar
• Mou X, Liu S. MiR-485 inhibits metastasis and EMT of lung adenocarcinoma by targeting Flot2. Biochem Biophys Res Commun. 2016;477(4):521–526.
   PubMed Web of Science ®Google Scholar
• Faversani A, Amatori S, Augello C, et al. miR-494-3p is a novel tumor driver of lung carcinogenesis. Oncotarget. 2017;8(5):7231–7247.
   PubMed Web of Science ®Google Scholar
• Chen T, Ren H, Thakur A, et al. miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer. Biomed Pharmacother. 2017;86:248–253.
   PubMed Web of Science ®Google Scholar
• Li L, Tan J, Zhang Y, et al. DLK1 promotes lung cancer cell invasion through upregulation of MMP9 expression depending on Notch signaling. PLoS One. 2014;9(3):e91509.
   PubMed Web of Science ®Google Scholar
• Molina-Pinelo S, Salinas A, Moreno-Mata N, et al. Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer. Oncotarget. 2016.
   Google Scholar
• Lu KH, Li W, Liu XH, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013;13:461.
   PubMed Web of Science ®Google Scholar
• Xia Y, He Z, Liu B, et al. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/beta-catenin signaling pathway. Mol Med Rep. 2015;12(3):4530–4537.
   PubMed Web of Science ®Google Scholar
• Azarbarzin S, Hosseinpour Feizi MA, Safaralizadeh R, et al. The value of miR-299-5p in diagnosis and prognosis of intestinal-type gastric adenocarcinoma. Biochem Genet. 2016;54(4):413–420.
   PubMed Web of Science ®Google Scholar
• Bernardo BC, Nguyen SS, Gao XM, et al. Inhibition of miR-154 protects against cardiac dysfunction and fibrosis in a mouse model of pressure overload. Sci Rep. 2016;6:22442.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang X, Klibanski A. Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma. Mol Cell Endocrinol. 2014;386(1–2):16–33.
   PubMed Web of Science ®Google Scholar
• Tang W, Shen Z, Guo J, et al. Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-beta induction in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2951–2964.
   PubMed Web of Science ®Google Scholar
• Geraldo MV, Nakaya HI, Kimura ET. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer. Oncotarget. 2017;8(6):9597–9607.
   PubMed Web of Science ®Google Scholar
• Anwar SL, Krech T, Hasemeier B, et al. Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma. PLoS One. 2012;7(11):e49462.
   PubMed Web of Science ®Google Scholar
• Valleron W, Laprevotte E, Gautier EF, et al. Specific small nucleolar RNA expression profiles in acute leukemia. Leukemia. 2012;26(9):2052–2060.
   PubMed Web of Science ®Google Scholar
• Lucon DR, Rocha Cde S, Craveiro RB, et al. Downregulation of 14q32 microRNAs in primary human desmoplastic medulloblastoma. Front Oncol. 2013;3:254.
   PubMedGoogle Scholar
• Lehner B, Kunz P, Saehr H, et al. Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone. BMC Cancer. 2014;14:495.
   PubMed Web of Science ®Google Scholar
• Devor EJ, Dem JN, Ramachandran S, et al. Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma. Exp Ther Med. 2012;3(4):677–682.
   PubMed Web of Science ®Google Scholar
• Gao Y, Liu T, Huang Y. MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins. FEBS Lett. 2015;589(2):207–214.
   PubMed Web of Science ®Google Scholar
• Sun CC, Li SJ, Li DJ. Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1. Oncotarget. 2016;7(24):35960–35978.
   PubMed Web of Science ®Google Scholar
• Yin D, Xie D, Sakajiri S, et al. DLK1: increased expression in gliomas and associated with oncogenic activities. Oncogene. 2006;25(13):1852–1861.
   PubMed Web of Science ®Google Scholar
• Ceder JA, Jansson L, Helczynski L, et al. Delta-like 1 (Dlk-1), a novel marker of prostate basal and candidate epithelial stem cells, is downregulated by notch signalling in intermediate/transit amplifying cells of the human prostate. Eur Urol. 2008;54(6):1344–1353.
   PubMed Web of Science ®Google Scholar
• Xu X, Liu RF, Zhang X, et al. DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma. Mol Cancer Ther. 2012;11(3):629–638.
   PubMed Web of Science ®Google Scholar
• Yu F, Hao X, Zhao H, et al. Delta-like 1 contributes to cell growth by increasing the interferon-inducible protein 16 expression in hepatocellular carcinoma. Liver Int. 2010;30(5):703–714.
   PubMed Web of Science ®Google Scholar
• Liu J, Wan L, Lu K, et al. The long noncoding RNA MEG3 contributes to cisplatin resistance of human lung adenocarcinoma. PLoS One. 2015;10(5):e0114586.
   PubMed Web of Science ®Google Scholar
• Su L, Han D, Wu J, et al. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163. Tumour Biol. 2016;37(3):3925–3931.
   PubMed Web of Science ®Google Scholar
• Kruer TL, Dougherty SM, Reynolds L, et al. Expression of the lncRNA maternally expressed gene 3 (MEG3) contributes to the control of lung cancer cell proliferation by the Rb pathway. PLoS One. 2016;11(11):e0166363.
   PubMed Web of Science ®Google Scholar
• Terashima M, Tange S, Ishimura A, et al. MEG3 long noncoding RNA contributes to the epigenetic regulation of epithelial-mesenchymal transition in lung cancer cell lines. J Biol Chem. 2017;292(1):82–99.
   PubMed Web of Science ®Google Scholar
• Milosevic J, Pandit K, Magister M, et al. Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2012;47(6):879–887.
   PubMed Web of Science ®Google Scholar
• Berenstein R, Blau O, Nogai A, et al. Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region. BMC Cancer. 2015;15:68.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Seike M, Takeuchi S, et al. MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma. Oncol Rep. 2014;32(6):2365–2372.
   PubMed Web of Science ®Google Scholar
• Maynard MA, Marino-Enriquez A, Fletcher JA, et al. Thyroid hormone inactivation in gastrointestinal stromal tumors. N Engl J Med. 2014;370(14):1327–1334.
   PubMed Web of Science ®Google Scholar
• Lempiainen H, Couttet P, Bolognani F, et al. Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion. Toxicol Sci. 2013;131(2):375–386.
   PubMed Web of Science ®Google Scholar
• Ramesh V, Ganesan K. Integrative analysis of transcriptome and miRNome unveils the key regulatory connections involved in different stages of hepatocellular carcinoma. Genes Cells. 2016;21(9):949–965.
   PubMed Web of Science ®Google Scholar
• Shu J, Li L, Sarver AE, et al. Imprinting defects at human 14q32 locus alters gene expression and is associated with the pathobiology of osteosarcoma. Oncotarget. 2016;7(16):21298–21314.
   PubMed Web of Science ®Google Scholar
• Chang C, Liu T, Huang Y, et al. MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A. Gene. 2017;605:99–107.
   PubMed Web of Science ®Google Scholar
• El-Daly SM, Abba ML, Patil N, et al. miRs-134 and −370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling. Sci Rep. 2016;6:24720.
   PubMed Web of Science ®Google Scholar
• Laddha SV, Nayak S, Paul D, et al. Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers. Biol Direct. 2013;8:10.
   PubMed Web of Science ®Google Scholar
• Tsang EK, Abell NS, Li X, et al. Small RNA sequencing in cells and exosomes identifies eQTLs and 14q32 as a region of active export. G3 (Bethesda). 2017;7(1):31–39.
   PubMedGoogle Scholar
• Haga CL, Phinney DG. MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network. J Biol Chem. 2012;287(51):42695–42707.
   PubMed Web of Science ®Google Scholar
• Hirota T, Date Y, Nishibatake Y, et al. Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues. Lung Cancer. 2012;77(1):16–23.
   PubMed Web of Science ®Google Scholar